Legato Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
112,820
-270
| -0.2% | -$2.51K | 0.12% | 260 |
|
|
2025
Q1 | $829K | Sell |
113,090
-1,730
| -2% | -$12.7K | 0.11% | 303 |
|
|
2024
Q4 | $981K | Sell |
114,820
-34,695
| -23% | -$296K | 0.13% | 303 |
|
|
2024
Q3 | $1.3M | Hold |
149,515
| – | – | 0.16% | 225 |
|
|
2024
Q2 | $1.02M | Hold |
149,515
| – | – | 0.14% | 252 |
|
|
2024
Q1 | $1.36M | Hold |
149,515
| – | – | 0.16% | 205 |
|
|
2023
Q4 | $667K | Buy |
+149,515
| New | +$667K | 0.09% | 353 |
|
|
2023
Q3 | – | Sell |
-116,389
| Closed | -$601K | – | 615 |
|
|
2023
Q2 | $601K | Buy |
+116,389
| New | +$601K | 0.08% | 383 |
|